AVTR
Avantor, Inc.
NYSE · Healthcare · Medical - Instruments & Supplies · US
$14.97
−1.45%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
17.3x
EV/EBITDA
107.9x
Market Cap
$10.13B
MomentumView details →
1D Return
−1.45%
YTD Return
+31.11%
RSI (14)
67.9
ValuationView details →
P/E (Fwd)
17.3x
EV/EBITDA
107.9x
Market Cap
$10.13B
RSI (14)
67.9
MomentumView details →
1D Return
−1.45%
YTD Return
+31.11%
SummaryUpdated Jun 1, 2026
Avantor, Inc. (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the life sciences and advanced technology industries. Founded in 1904 and headquartered in Radnor, Pennsylvania, the company went public in May 2019. Avantor serves customers across biopharma, healthcare, education and government, advanced technologies, and applied materials industries worldwide. The company has evolved from its origins as a specialty chemicals provider into a comprehensive solutions partner for organizations conducting critical research, development, and production activities.
Similar companies
Latest newsMore news →
Advisors Capital Management LLC disclosed a new minority stake in Avantor, Inc. by purchasing 441,317 shares worth approximately $4.37 million during the second quarter, according to its 13F filing.14d agoAvantor, Inc. amended its 2017 credit agreement to add a €374.2 million tranche of Incremental B-7 Euro Term Loans, refinancing existing senior secured euro term loans and reducing the interest rate spread from 2.50% to 2.00% over EURIBOR, with the maturity date retained as October 9, 2032.50d ago